Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 106 participants.
Also called NCT06197022
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 106 participants
- Registry
-
NCT06197022
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Bulgaria
- Registry status
- Unknown status
Technical summary
Registry record NCT06197022. Non-randomized; no masking; primary purpose treatment. Start 2022-10-01 (actual); primary completion 2024-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)
- Acronym
- SCA-DEB
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Mozec™ SEB Sirolimus Eluting Rx PTCA Balloon Dilatation Catheter
- Lead sponsor
- University National Heart Hospital
- Collaborator
- Meril Life Sciences Pvt. Ltd.
Record details
- Record id
cardio:ct-nct06197022- Content hash
08702c1592a58dc66b2b9b43900d0c595dcf5629f8e661d298e73fb972cfc75a